Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

Coronavirus disease 2019 (COVID-19) is a viral infection affecting multiple organ systems of great significance for metabolic processes. Thus, there is increasing interest in metabolic and lipoprotein signatures of the disease, and early analyses have demonstrated a metabolic pattern typical for ath...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Franziska Schmelter, Bandik Föh, Alvaro Mallagaray, Johann Rahmöller, Marc Ehlers, Selina Lehrian, Vera von Kopylow, Inga Künsting, Anne Sophie Lixenfeld, Emily Martin, Mohab Ragab, Roza Meyer-Saraei, Fabian Kreutzmann, Ingo Eitel, Stefan Taube, Nadja Käding, Eckard Jantzen, Tobias Graf, Christian Sina, Ulrich L. Günther
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
NMR
metabolomics
SARS-CoV-2
COVID-19
lipoproteins
Biology (General)
QH301-705.5
Acceso en línea:https://doaj.org/article/bbbf11393234463db0d98a3642a824c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares